NanoLogix, Inc. (NNLX)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 14, 2025
NanoLogix Revenue
NanoLogix had revenue of $128.00 in the quarter ending June 30, 2012. This brings the company's revenue in the last twelve months to $1.27K, up 139.02% year-over-year. In the year 2011, NanoLogix had annual revenue of $892.00 with 39.38% growth.
Revenue (ttm)
1.27K
Revenue Growth
+139.02%
P/S Ratio
0.13
Revenue / Employee
182.00
Employees
7
Market Cap
163.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2011 | 892.00 | 252.00 | 39.38% |
| Dec 31, 2010 | 640.00 | -20.72K | -97.00% |
| Dec 31, 2009 | 21.36K | -3.64K | -14.56% |
| Dec 31, 2008 | 25.00K | 4.38K | 21.25% |
| Dec 31, 2007 | 20.62K | - | - |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 1998 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 206.83M |
| Elite Pharmaceuticals | 84.04M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| BioStem Technologies | 332.45M |